---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-001254"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:27:29.004780+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q2 2025 revenue $7.3M, net loss $1.0M; ships 19 SRT systems, FDA volume up 27% sequentially

## Summary
- Revenue $7.3M vs $9.2M YoY; net loss $1.0M ($0.06/sh) vs net income $1.6M ($0.10/sh) in Q2 2024.
- Shipped 19 SRT systems, including 4 to China; signed 5 new Fair Deal Agreements, 4 live; FDA volume +27% seq.
- Gross margin fell to 39.7% from 58.7% on lower sales and higher service costs; adjusted EBITDA negative $1.8M.
- Ended quarter with $22.2M cash and no debt; engaged Radiology Oncology Systems as distribution partner for hospitals.
- Proposed Physician Fee Schedule expected to align outpatient SRT reimbursement with hospital rates starting Jan 2026.

## SEC filing metadata
- accession: 0001753926-25-001254
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000175392625001254/0001753926-25-001254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000175392625001254/g084908_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-001254
- JSON: https://secwatch.observer/filing/0001753926-25-001254.json
- Plain text: https://secwatch.observer/filing/0001753926-25-001254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.